Fenofibrate 130mg Capsules

Manufacturer APOTEX Active Ingredient Fenofibrate and Derivatives Capsules(fen oh FYE brate & dah RIV ah tives) Pronunciation fen oh FYE brate
It is used to lower bad cholesterol, lower triglycerides, and raise good cholesterol (HDL).
🏷️
Drug Class
Antilipemic agent
🧬
Pharmacologic Class
Peroxisome proliferator-activated receptor alpha (PPARΞ±) agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Dec 1993
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fenofibrate is a medication used to help lower high levels of triglycerides (a type of fat) and cholesterol in your blood. It works by helping your body process fats more effectively. It's often used along with diet changes and exercise to improve your lipid levels and reduce the risk of heart problems.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Some brands of this medication should be taken with food, while others can be taken with or without food. Check with your pharmacist to see if your brand needs to be taken with food. If you have difficulty swallowing, consult with your doctor.

Take your medication with a full glass of water. If you are also taking cholestyramine or colestipol, take these medications at least 4 hours before or 1 hour after your prescribed medication.

Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better. Swallow the medication whole; do not chew, crush, open, or dissolve it.

Storing and Disposing of Your Medication

Store your medication at room temperature with the lid tightly closed. Some brands require storage in the original container, so do not remove the anti-moisture cube or packet. If you are unsure about the storage requirements for your brand, consult with your doctor or pharmacist.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular dosing schedule. Do not take more than one dose in a 24-hour period unless your doctor instructs you to do so.
πŸ’‘

Lifestyle & Tips

  • Continue to follow a low-fat, low-cholesterol diet as recommended by your doctor or dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Maintain a healthy weight.
  • Limit alcohol intake.
  • Quit smoking.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 130 mg (or 145 mg depending on formulation) orally once daily with meals
Dose Range: 48 - 145 mg

Condition-Specific Dosing:

severeHypertriglyceridemia: 130 mg (or 145 mg) orally once daily with meals
primaryHypercholesterolemiaMixedDyslipidemia: 130 mg (or 145 mg) orally once daily with meals
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dose adjustment needed for CrCl 60-80 mL/min.
Moderate: Reduce dose to 48 mg (or 50 mg) orally once daily for CrCl 30-59 mL/min. Monitor renal function.
Severe: Contraindicated for CrCl < 30 mL/min.
Dialysis: Contraindicated in patients with end-stage renal disease (ESRD) requiring dialysis.

Hepatic Impairment:

Mild: Use with caution; monitor liver function.
Moderate: Contraindicated in active liver disease, including primary biliary cirrhosis and unexplained persistent liver function abnormalities.
Severe: Contraindicated in active liver disease, including primary biliary cirrhosis and unexplained persistent liver function abnormalities.

Pharmacology

πŸ”¬

Mechanism of Action

Fenofibrate is a prodrug that is rapidly hydrolyzed to its active metabolite, fenofibric acid. Fenofibric acid activates peroxisome proliferator-activated receptor alpha (PPARΞ±), a nuclear receptor that regulates lipid metabolism. Activation of PPARΞ± leads to increased lipolysis and elimination of triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing production of apolipoprotein C-III (an inhibitor of lipoprotein lipase). It also increases the synthesis of apolipoproteins A-I and A-II, leading to increased HDL-C levels. These actions result in a reduction in total cholesterol, LDL-C, VLDL-C, and triglycerides, and an increase in HDL-C.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Variable (enhanced with food, specific formulations like 130mg are micronized or nanocrystallized for improved absorption)
Tmax: 4-6 hours (for fenofibric acid)
FoodEffect: Absorption is increased by approximately 35% when taken with food. The 130mg capsule formulation is designed to be taken with food for optimal absorption.

Distribution:

Vd: Not readily available for fenofibric acid, but extensively distributed.
ProteinBinding: >99% (fenofibric acid to plasma albumin)
CnssPenetration: Limited

Elimination:

HalfLife: 20-23 hours (for fenofibric acid)
Clearance: Not readily available, primarily renal excretion.
ExcretionRoute: Primarily renal (approximately 60-70% as fenofibric acid and its glucuronide), with a small amount excreted in feces (approximately 25%).
Unchanged: <2% (fenofibric acid in urine)
⏱️

Pharmacodynamics

OnsetOfAction: Within days to weeks for lipid-lowering effects.
PeakEffect: Maximal lipid-lowering effects typically observed within 6-8 weeks of therapy.
DurationOfAction: Maintained with once-daily dosing due to long half-life.

Safety & Warnings

⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be life-threatening.
Liver problems: Dark urine, tiredness, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
Pancreas problems (pancreatitis): Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Gallstones: Sudden pain in the upper right belly area, right shoulder area, or between the shoulder blades, yellow skin or eyes, or fever with chills.
Severe joint pain or swelling: Contact your doctor if you experience very bad joint pain or swelling.
Blood clots: Chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, change of color, or pain in a leg or arm, or trouble speaking or swallowing.
Muscle problems: Muscle pain or weakness, especially if you feel very tired or weak or have a fever. This can also lead to kidney problems. Inform your doctor if you have difficulty urinating or notice a change in your urine output.
Severe skin reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions can occur, which may be life-threatening. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or any areas of skin; fever; chills; body aches; shortness of breath; or swollen glands.
Low blood cell counts: This can lead to bleeding problems, infections, or anemia. Contact your doctor if you have signs of infection, such as fever, chills, or sore throat; unexplained bruising or bleeding; or if you feel very tired or weak.

Other Side Effects

Most people do not experience significant side effects, but some may occur. If you are concerned about any of the following side effects or if they persist, contact your doctor:

Headache
Back pain
Stomach pain

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Muscle pain, tenderness, or weakness (especially if accompanied by fever or feeling unwell)
  • Dark-colored urine
  • Yellowing of your skin or the whites of your eyes (jaundice)
  • Severe stomach pain (with or without nausea and vomiting)
  • Unusual bleeding or bruising
  • Swelling in your hands or feet
  • Signs of an allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the symptoms you experienced.
Certain health conditions, such as gallbladder disease, kidney disease, liver disease, or elevated liver enzymes.
If you are taking any of the following medications: atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, or simvastatin.
If you are breastfeeding or plan to breastfeed. Note that you should not breastfeed while taking this medication, and you may need to avoid breastfeeding for 5 days after your last dose. Consult your doctor to determine the best course of action.

Please note that this is not an exhaustive list of potential interactions. To ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter medications, natural products, and vitamins.
Discuss all your health problems with your doctor.
Verify that it is safe to take this medication with all your other medications and health conditions.
Do not start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests should be conducted as directed by your doctor to monitor your condition. Adhere to the diet and exercise plan recommended by your doctor to ensure optimal management of your health.

Be aware that this medication can cause liver problems, which may be severe and potentially life-threatening, requiring a liver transplant or resulting in death. If you have any concerns or questions, discuss them with your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to experiencing side effects.

If you are pregnant or planning to become pregnant, consult your doctor to discuss the potential benefits and risks associated with using this medication during pregnancy.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • No specific symptoms of overdose have been reported, but potential effects could include severe muscle pain, liver dysfunction, or kidney problems.

What to Do:

In case of suspected overdose, contact a poison control center immediately (1-800-222-1222 in the US) or seek emergency medical attention. Treatment is generally supportive and symptomatic, as fenofibric acid is highly protein bound and not effectively removed by hemodialysis.

Drug Interactions

πŸ”΄

Major Interactions

  • Statins (HMG-CoA reductase inhibitors): Increased risk of myopathy/rhabdomyolysis.
  • Oral anticoagulants (e.g., Warfarin): Potentiation of anticoagulant effect, increased risk of bleeding.
  • Cyclosporine: Increased risk of renal dysfunction.
🟑

Moderate Interactions

  • Bile acid sequestrants (e.g., Cholestyramine, Colestipol, Colesevelam): May reduce absorption of fenofibrate. Administer fenofibrate at least 1 hour before or 4-6 hours after bile acid sequestrants.
  • Colchicine: Increased risk of myopathy/rhabdomyolysis.

Monitoring

πŸ”¬

Baseline Monitoring

Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides)

Rationale: To establish baseline lipid levels and assess the need for therapy.

Timing: Prior to initiation of therapy.

Liver Function Tests (ALT, AST)

Rationale: To assess baseline liver function, as fenofibrate can cause transaminase elevations and is contraindicated in active liver disease.

Timing: Prior to initiation of therapy.

Renal Function (Serum Creatinine, eGFR/CrCl)

Rationale: To assess baseline renal function, as fenofibrate is primarily renally eliminated and dose adjustments are required in renal impairment.

Timing: Prior to initiation of therapy.

Complete Blood Count (CBC)

Rationale: To assess for potential hematologic abnormalities, though less common.

Timing: Prior to initiation of therapy.

πŸ“Š

Routine Monitoring

Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides)

Frequency: Every 4-8 weeks initially, then every 6-12 months once stable.

Target: Individualized based on treatment goals (e.g., TG < 150 mg/dL, LDL-C and HDL-C goals per guidelines).

Action Threshold: Failure to achieve lipid goals, or significant adverse changes in lipid profile.

Liver Function Tests (ALT, AST)

Frequency: Every 3 months during the first year of treatment, then periodically (e.g., annually) thereafter.

Target: Within normal limits (typically < 3 times upper limit of normal).

Action Threshold: Persistent ALT/AST elevations > 3 times ULN; discontinue fenofibrate.

Renal Function (Serum Creatinine, eGFR/CrCl)

Frequency: Periodically, especially in elderly patients or those with pre-existing renal impairment.

Target: Stable, within acceptable limits for patient's age and baseline.

Action Threshold: Significant increase in serum creatinine or decrease in eGFR; consider dose adjustment or discontinuation.

Complete Blood Count (CBC)

Frequency: Periodically, if clinically indicated.

Target: Within normal limits.

Action Threshold: Significant decrease in hemoglobin, hematocrit, or white blood cell count.

Creatine Kinase (CK)

Frequency: If muscle pain, tenderness, or weakness occurs.

Target: Within normal limits.

Action Threshold: Significant elevation (> 5 times ULN) or symptoms of myopathy; discontinue fenofibrate.

πŸ‘οΈ

Symptom Monitoring

  • Unexplained muscle pain, tenderness, or weakness (especially if accompanied by fever or malaise)
  • Dark urine
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain (pancreatitis, gallstones)
  • Nausea, vomiting, loss of appetite
  • Unusual bleeding or bruising

Special Patient Groups

🀰

Pregnancy

Fenofibrate is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Potential for fetal harm based on animal studies (skeletal malformations, reduced fetal weight, increased fetal mortality at high doses).
Second Trimester: Potential for fetal harm based on animal studies.
Third Trimester: Potential for fetal harm based on animal studies.
🀱

Lactation

It is not known whether fenofibric acid is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Unknown; potential for serious adverse reactions.
πŸ‘Ά

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. Use is generally not recommended.

πŸ‘΄

Geriatric Use

Use with caution in elderly patients due to the greater frequency of decreased renal function. Monitor renal function periodically. Dose adjustments may be necessary based on renal function.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fenofibrate should be taken with meals to optimize absorption, especially the 130mg capsule formulation.
  • Regular monitoring of liver function tests (ALT/AST) and renal function (CrCl) is crucial, especially during the first year of treatment and in patients with pre-existing renal impairment.
  • Patients should be advised to report any unexplained muscle pain, tenderness, or weakness immediately, as this could indicate myopathy or rhabdomyolysis, particularly when co-administered with statins.
  • Fenofibrate can potentiate the effects of oral anticoagulants (e.g., warfarin), requiring careful monitoring of INR and potential dose adjustment of the anticoagulant.
  • While primarily used for hypertriglyceridemia, fenofibrate also has beneficial effects on HDL-C and can reduce LDL-C, making it useful for mixed dyslipidemia.
  • Contraindicated in patients with active liver disease, severe renal impairment, or pre-existing gallbladder disease.
πŸ”„

Alternative Therapies

  • Statins (e.g., Atorvastatin, Rosuvastatin, Simvastatin) - primary for LDL-C lowering, some TG lowering.
  • Omega-3 Fatty Acid Esters (e.g., Icosapent ethyl, Omega-3-acid ethyl esters) - primarily for severe hypertriglyceridemia.
  • Niacin (Nicotinic Acid) - for mixed dyslipidemia, but with significant side effects.
  • PCSK9 Inhibitors (e.g., Alirocumab, Evolocumab) - primarily for severe hypercholesterolemia, some TG lowering.
  • Bempedoic Acid - for LDL-C lowering.
  • Ezetimibe - for LDL-C lowering.
πŸ’°

Cost & Coverage

Average Cost: $30 - $150 per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it occurred.